Your browser doesn't support javascript.
loading
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris, S; Papadakis, E; Tsiafaki, X; Kalofonos, C; Rapti, A; Toubis, M; Bania, E; Kouroussis, C; Chainis, K; Androulakis, N; Agelaki, S; Sarra, E; Vardakis, N; Georgoulias, V.
Affiliation
  • Kakolyris S; Department of Medical Oncology, University General Hospital of Heraklion, Heraklion 71110, Crete, Greece
Lung Cancer ; 32(2): 179-87, 2001 May.
Article in En | MEDLINE | ID: mdl-11325489
Search on Google
Collection: 01-internacional Health context: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Paclitaxel / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms / Neutropenia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Year: 2001 Document type: Article
Search on Google
Collection: 01-internacional Health context: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Paclitaxel / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms / Neutropenia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Year: 2001 Document type: Article